UK markets closed

Fresenius SE & Co. KGaA (FSNUF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
29.480.00 (0.00%)
At close: 10:07AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close29.48
Bid0.00 x 0
Ask0.00 x 0
Day's range29.48 - 29.48
52-week range29.48 - 52.94
Avg. volume401
Market cap16.984B
Beta (5Y monthly)1.21
PE ratio (TTM)8.70
EPS (TTM)3.39
Earnings dateN/A
Forward dividend & yield0.96 (3.27%)
Ex-dividend date16 May 2022
1y target est13.74
  • Reuters

    Fresenius plans to cut 2,000 jobs globally at Kabi unit - Handelsblatt

    In Germany, 250 jobs would be affected, the paper said. Fresenius, which runs dialysis centers and hospitals, makes generic drugs and helps plan hospital construction projects, last year launched a group-wide cost cutting programme to become more competitive amid a declining share price over several years.

  • Reuters

    Fresenius warns of bigger Ukraine war impact after Q1 profit beat

    German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely to increase this year, fuelled by Russia's invasion of Ukraine. Fresenius's businesses include the Helios hospital chain, drugmaker Kabi, medical services firm Vamed and dialysis specialist Fresenius Medical Care (FMC).

  • Zacks

    Omnicell (OMCL) Inks New Deal to Manage Controlled Substances

    Omnicell (OMCL), Fresenius Kabi collaborate to offer safe and efficient dispensing of controlled substances across hospitals and health systems in the United States.